Immunology Archives - Baylor College of Medicine Blog Network

Dr. Thomas Kosten develops anti-Fentanyl vaccine

May 9, 2023 Fentanyl, Immunology, Neuroscience, opioid, overdose, pharmacology, Psychiatry, vaccine

Each year, more Americans die from drug overdoses than in traffic accidents. More than three out of five of these deaths are the result of

A couple holds hands while on a walk outdoors with their pitbull.

Momentum

Exercise helps alleviate osteoarthritis, according to Baylor study

August 29, 2022 Arthritis, Exercise, Immunology, Immunology Allergy and Rheumatology, joint pain

Dr. Grace Hsiao-Wei Lo explains the different types of arthritis and how exercise can be a helpful treatment.

Momentum

Are herbal supplements safe?

January 20, 2021 Healthcare, Immunology, Kaylee Dusang

Dr. Donald Marcus discusses the health risks of using all-natural dietary supplements made from herbal plants.

From The Labs

Image of the Month: Human natural killer cells preparing to deliver a lethal strike to diseased cells

December 2, 2016 alpha-tubulin, cancer cells, Immunology, lytic vesicles, microtubules, NK cells, primary immunodeficiency disease, viral infections

This mosaic montage of still images of live natural killer (NK) cells from the human immune system shows the cells have a skeleton of microtubules

From The Labs

Genomic approaches can provide answers to undiagnosed primary immunodeficiency diseases.

November 18, 2016 Genetic Sequencing, Human genetics, Immunology, molecular causes of disease, next generation genome sequencing, PIDD, primary immunodeficiency disease

Lea este artículo en español, aquí. An international team of physician-researchers set out to change the approach by which they genetically diagnose primary immunodeficiency diseases

From The Labs

Targeting B-cell malignancies with κ-specific T cells can lead to complete clinical responses

August 9, 2016 antibody light chains, B-cell lymphoma, Cancer, chimeric antigen receptor, Immunology, Immunotherapy, T lymphocytes

Treating cancer with the patient’s own immune cells has been successful. In particular, treating B cell malignancies with the patients’ own immune T cells modified